DENTSPLY SIRONA (NASDAQ:XRAY – Free Report) had its target price lowered by Wells Fargo & Company from $20.00 to $19.00 in a research note issued to investors on Friday morning,Benzinga reports. The brokerage currently has an equal weight rating on the medical instruments supplier’s stock.
XRAY has been the topic of a number of other research reports. Leerink Partners cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Tuesday, February 18th. Needham & Company LLC decreased their price target on DENTSPLY SIRONA from $25.00 to $23.00 and set a “buy” rating for the company in a research note on Friday. Barrington Research lowered their price target on DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a report on Friday. Finally, Robert W. Baird reduced their price objective on DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a report on Friday. Eleven equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $23.58.
Check Out Our Latest Stock Report on XRAY
DENTSPLY SIRONA Stock Performance
DENTSPLY SIRONA Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 3.87%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -30.92%.
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in XRAY. Capital Performance Advisors LLP purchased a new stake in shares of DENTSPLY SIRONA in the 3rd quarter worth $27,000. Kennebec Savings Bank purchased a new position in shares of DENTSPLY SIRONA in the third quarter valued at about $35,000. Colonial Trust Co SC purchased a new stake in DENTSPLY SIRONA during the 4th quarter valued at approximately $26,000. Riverview Trust Co purchased a new position in DENTSPLY SIRONA during the fourth quarter valued at $26,000. Finally, MassMutual Private Wealth & Trust FSB lifted its position in shares of DENTSPLY SIRONA by 648.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock worth $27,000 after buying an additional 1,232 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Read More
- Five stocks we like better than DENTSPLY SIRONA
- Stock Dividend Cuts Happen Are You Ready?
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- How to Invest in Biotech Stocks
- 5 Best Gold ETFs for March to Curb Recession Fears
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.